Prednisolone Acetate



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 36.5%
Postoperative Care 19.3%
Local Anaesthesia 4.6%
Lymphoma 4.6%
Product Used For Unknown Indication 4.4%
Chronic Obstructive Pulmonary Disease 4.1%
Rosacea 3.6%
Uveitis 2.3%
Evans Syndrome 2.1%
Prophylaxis Against Transplant Rejection 2.1%
Systemic Lupus Erythematosus 2.1%
Endophthalmitis 1.8%
Iridocyclitis 1.8%
Rheumatoid Arthritis 1.8%
Ulcerative Keratitis 1.8%
Cataract Operation 1.5%
Immunosuppression 1.5%
Scleritis 1.5%
Diabetes Mellitus 1.3%
Infection Prophylaxis 1.3%
Fibrous Histiocytoma 8.1%
Transplant Rejection 8.1%
Intraocular Pressure Increased 7.0%
Ulcerative Keratitis 7.0%
Drug Ineffective 5.8%
Melaena 5.8%
Parophthalmia 5.8%
Visual Acuity Reduced 5.8%
Pregnancy 4.7%
Product Substitution Issue 4.7%
Stillbirth 4.7%
Weight Decreased 4.7%
Acute Generalised Exanthematous Pustulosis 3.5%
Eye Irritation 3.5%
Jaundice 3.5%
Macular Fibrosis 3.5%
Precursor T-lymphoblastic Lymphoma/leukaemia 3.5%
Renal Impairment 3.5%
Therapeutic Response Unexpected With Drug Substitution 3.5%
Uveitis 3.5%
Secondary
Cataract Operation 35.2%
Renal Transplant 7.6%
Product Used For Unknown Indication 7.0%
Postoperative Care 6.6%
Idiopathic Thrombocytopenic Purpura 5.5%
Rheumatoid Arthritis 4.2%
Burkitt's Lymphoma 3.3%
Diffuse Large B-cell Lymphoma 3.3%
Liver Transplant 3.3%
Stem Cell Transplant 3.3%
Prophylaxis 2.7%
Prostate Cancer Metastatic 2.5%
Analgesic Therapy 2.3%
Eye Oedema 2.3%
Preoperative Care 2.0%
Prophylaxis Against Transplant Rejection 2.0%
Glaucoma 1.8%
Hypertension 1.7%
Immunosuppression 1.7%
Mantle Cell Lymphoma 1.7%
Toxic Anterior Segment Syndrome 32.1%
White Blood Cell Count Increased 10.1%
Endophthalmitis 6.4%
Graft Versus Host Disease 4.6%
Intraocular Pressure Increased 4.6%
Neutropenia 3.7%
Pleural Effusion 3.7%
Tumour Lysis Syndrome 3.7%
Vision Blurred 3.7%
Vitreous Opacities 3.7%
Eye Pain 2.8%
Off Label Use 2.8%
Pyrexia 2.8%
Retinal Detachment 2.8%
Swelling Face 2.8%
Transplant Rejection 2.8%
Acute Generalised Exanthematous Pustulosis 1.8%
Bacterial Sepsis 1.8%
Corneal Deposits 1.8%
Corneal Infiltrates 1.8%
Concomitant
Product Used For Unknown Indication 21.5%
Prophylaxis 15.1%
Aplastic Anaemia 9.1%
Drug Use For Unknown Indication 7.6%
Infection Prophylaxis 6.8%
Hiv Infection 4.2%
Pneumocystis Jiroveci Pneumonia 3.9%
Premedication 3.8%
Hypertension 3.7%
Renal Transplant 3.4%
Rheumatoid Arthritis 3.2%
Bone Marrow Conditioning Regimen 2.4%
Prophylaxis Against Gastrointestinal Ulcer 2.3%
Constipation 2.0%
Postoperative Care 2.0%
Prophylaxis Against Graft Versus Host Disease 1.9%
Acute Myeloid Leukaemia 1.8%
Pulmonary Tuberculosis 1.8%
Antiviral Prophylaxis 1.7%
Mantle Cell Lymphoma 1.6%
White Blood Cell Count Decreased 10.4%
Pneumonia 8.0%
Vomiting 7.5%
Weight Decreased 6.5%
White Blood Cell Count Increased 6.5%
Urinary Tract Infection 5.5%
Visual Acuity Reduced 5.5%
Sepsis 4.5%
Thrombotic Microangiopathy 4.5%
Vision Blurred 4.5%
Wheezing 4.5%
Renal Failure 4.0%
Toxic Anterior Segment Syndrome 4.0%
Uterine Haemorrhage 4.0%
Keratitis 3.5%
Pyrexia 3.5%
Respiratory Failure 3.5%
Therapeutic Response Decreased 3.5%
Throat Tightness 3.5%
Asthenia 3.0%
Interacting
Thoracic Vertebral Fracture 57.1%
Atrial Fibrillation 42.9%
Cardiac Disorder 100.0%